To identify the relevant priority actions to be taken in the framework of a sustainable development in terms of lowering presence, impacts, and risk of pharmaceutical products (PPs) in the environment.
1) To establish a list of pharmaceutical products (PPs) most relevant in terms of exposure in the aquatic environment, identifying major gaps in data availability and quality, 2) To investigate the elimination efficiency of treatment processes (sewage treatment, drinking water production, specific industrial processes), 3) To present an overview of the eco-toxicological significance and health impacts of PPs, 4) To develop a classification system to prioritise the environmental risks of PPs, thus supporting water managers and health authorities to minimise point and diffuse pollution of water, 5) To assess current regulatory and policy approaches at EU level and specific Member States and identify options for the design of future policy instruments to limit water pollution from PPs, 6) To make recommendations for environmental stewardship (pollution prevention and monitoring) integrating green technology and ecopharmacovigilance schemes.
HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.
